ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News

Kennedy Allies Petition to Broaden US Vaccine Injury List

An anti-vaccine group aligned with U.S. Health Secretary Robert F. Kennedy Jr. is petitioning him to vastly broaden a federal list to include more than 300 injuries it says...

Kids Confirmed as Top Transmitters of RSV

New modeling data support targeted prevention efforts.

Kent Meningitis Outbreak Triggers Surge in UK Vaccine Demand, Policy Debate

Young people in southeast England and beyond are lining up for the meningitis B vaccine after an outbreak killed two people, sparking supply warnings from pharmacies and...

Parasitic Worms Provide Insights on RSV Prevention

Researchers identify metabolite alternatives to helminth-influenced protection.

Viral Coinfection May Predict Bacteremic Pneumonia

Patients with respiratory viral co-infection may have an increased risk of developing bacteremic Staphylococcus aureus pneumonia and 30-day mortality compared with those without viral co-infection.

UK Says Vaccine Protects Against Strain in Deadly Meningitis Outbreak

Britain's health authorities said on Friday that early laboratory analysis had shown the vaccine being ⁠offered to students should protect against the strain of meningitis...

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Latest News

An anti-vaccine group aligned with U.S. Health Secretary Robert F. Kennedy Jr. is petitioning him to vastly broaden a federal list to include more than 300 injuries it says...

New modeling data support targeted prevention efforts.

Young people in southeast England and beyond are lining up for the meningitis B vaccine after an outbreak killed two people, sparking supply warnings from pharmacies and...

Researchers identify metabolite alternatives to helminth-influenced protection.

Patients with respiratory viral co-infection may have an increased risk of developing bacteremic Staphylococcus aureus pneumonia and 30-day mortality compared with those without viral co-infection.

Britain's health authorities said on Friday that early laboratory analysis had shown the vaccine being ⁠offered to students should protect against the strain of meningitis...

News All Time

US Insurers and Hospitals Turn to New AI for Age-old Battle Over Charges Vs Payments

Artificial intelligence is being deployed on both sides of the tug-of-war between U.S. healthcare systems that want to be paid more for medical procedures and insurers who...

Viatris Settles lawsuit Over Use Of Woman's 'immortal' Cells to Power Drug Research

Generic drugmaker Viatris has settled a lawsuit brought by the family of Henrietta Lacks, a Maryland woman whose ⁠tissue samples were used without her permission to develop...

RSV Hospitalization Burden Rises With Age and Comorbidities

Respiratory syncytial virus is associated with a greater burden of hospitalizations in older adults and in those with congestive heart failure or chronic obstructive pulmonary disease.

US Vaccine Advisers Drop Plan to Question MRNA COVID Shots, WaPo Reports

A key U.S. federal vaccine advisory panel has dropped a push against COVID mRNA vaccines, ⁠the Washington Post reported on Wednesday, citing two people familiar with the...

No Link Between HPV Vaccination and Infertility

A Cochrane review of 225 studies covering 132 million vaccinated people found, with high certainty, that HPV vaccination does not cause fertility problems, refuting a common myth.

South Carolina Reports One Additional Measles Case, Total Cases Rise to 991

Measles cases in South Carolina rose to 991 on Friday, state health data ⁠showed, an increase of one case since Tuesday as the nation's largest outbreak in ⁠decades shows...

mRNA RSV Vaccine Safe in Transplant Recipients

mRNA-1345 vaccine is safe and well tolerated and elicits measurable antibody and cellular immune responses in recipients with solid organ transplant.

HIV Hits the Nervous System Early

Cerebrospinal fluid samples show signs of inflammation.

Exercise Training Benefits HIV Patients Below the Surface

Genetic analysis shows signs of cellular repair and slower aging.

Dolutegravir Shows Continued Success in Youth With HIV

Dolutegravir reduces viral load in adolescents and children in low- to middle-income nations.

US CDC Deploys Staff to Curb South Carolina's Measles Outbreak

(Refiles to remove extraneous word years from first paragraph)

After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax

The Moderna vaccine will likely be available in Europe long before the US.

Peak Anti-HBs Level May Predict Protection in HIV Infection

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Doravirine Plus Islatravir Matches Standard HIV Therapy

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

European Guidance Advances Cardiovascular Risk Assessment

The 2025 update integrates new risk estimation tools and shifts acute coronary syndrome management toward earlier intensive lipid-lowering therapy.

Exclusive-US Postpones Third Consecutive Meeting Of Preventive Health Panel

The March meeting of the U.S. advisory panel that determines what cancer screenings and other preventive health measures insurers must cover has been postponed, according to...

Recommended News For You

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

Research suggests peer support may lower depression, stress among cancer patients in low-resource settings

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

For elderly, unfit patients, the all-oral AML regimen shows promise.

According to JAMA, statin use may increase cancer-related survival in breast cancer patients.

Recommended Articles For You

The Importance of Balanced Potassium Levels in Maintaining Good Health 

Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era 

The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v 

Navigating the Complexities of Melanoma Staging: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Survivors of childhood brain cancer are more likely to be held back in school

2.

Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans

3.

Research uncovers hidden Australian skin cancer epidemic

4.

In 18 States, alcohol exclusion laws are still in effect.

5.

Study finds 10% of pediatric blood cancers may stem from medical imaging radiation

1.

Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked

2.

Liquid Biopsy: A Game-Changer in T-Cell Lymphoma Detection and Management

3.

Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025

4.

Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment

5.

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

3.

Current Scenario of Cancer- Q&A Session to Close the Gap

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot